Air–Liquid Interface Cell Exposures to Nanoparticle Aerosols
The field of nanomedicine is steadily growing and several nanomedicines are currently approved for clinical use with even more in the pipeline. Yet, while the use of nanotechnology to improve targeted drug delivery to the lungs has received some attention, the use of nanoparticles for inhalation drug delivery has not yet resulted in successful translation to market as compared to intravenous drug delivery. The reasons behind the lack of inhaled nanomedicines approved for clinical use or under preclinical development are unclear, but challenges related to safety are likely to contribute. Although inhalation toxicology studies often begin using animal models, there has been an increase in the development and use of in vitro air–liquid interface (ALI) exposure systems for toxicity testing of engineered nanoparticle aerosols, which will be useful for rapid testing of candidate substances and formulations. This chapter describes an ALI cell exposure assay for measuring toxicological effects, specifically cell viability and oxidative stress, resulting from exposure to aerosols containing nanoparticles.
Key wordsAir-interfaced culture SPIONs Iron oxide Nanoparticles Aerosol
- 1.OECD. Test No. 403: Acute Inhalation Toxicity. OECD PublishingGoogle Scholar
- 2.OECD. Test No. 436: Acute Inhalation Toxicity—Acute Toxic Class Method. OECD PublishingGoogle Scholar
- 10.Paur H-R, Cassee FR, Teeguarden J, Fissan H, Diabate S, Aufderheide M, Kreyling WG, Hänninen O, Kasper G, Riediker M, Rothen-Rutishauser B, Schmid O (2011) In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung—A dialog between aerosol science and biology. J Aerosol Sci 42(10):668–692. doi:10.1016/j.jaerosci.2011.06.005 CrossRefGoogle Scholar
- 11.Akrivi A, Emmanouil D, Nastassja L, Michael R, Eleni P, Athanasios GK (2013) Development of a dose-controlled multiculture cell exposure chamber for efficient delivery of airborne and engineered nanoparticles. J Phys Conf Ser 429(1):012023Google Scholar
- 13.Lenz AG, Karg E, Lentner B, Dittrich V, Brandenberger C, Rothen-Rutishauser B, Schulz H, Ferron GA, Schmid O (2009) A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles. Part Fibre Toxicol 6(1):1–17. doi:10.1186/1743-8977-6-32 CrossRefGoogle Scholar